← Back to Screener
UFP Technologies Inc (UFPT)
Price$194.04
Favorite Metrics
Price vs S&P 500 (26W)-4.08%
Price vs S&P 500 (4W)-6.92%
Market Capitalization$1.49B
P/E Ratio (Annual)21.86x
All Metrics
P/CF (Annual)16.25x
Book Value / Share (Quarterly)$54.95
P/TBV (Annual)6.05x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)19.44%
Cash Flow / Share (Quarterly)$10.24
Price vs S&P 500 (YTD)-14.27%
Gross Margin (TTM)28.27%
Net Profit Margin (TTM)11.33%
EPS (TTM)$8.76
10-Day Avg Trading Volume0.19M
EPS Excl Extra (TTM)$8.76
Revenue Growth (5Y)27.43%
EPS (Annual)$8.75
ROI (Annual)12.21%
Gross Margin (Annual)28.27%
Net Profit Margin (5Y Avg)10.75%
Cash / Share (Quarterly)$2.63
P/E Basic Excl Extra (TTM)21.86x
Revenue Growth QoQ (YoY)3.36%
EPS Growth (5Y)37.78%
P/E Normalized (Annual)21.86x
ROA (Last FY)10.43%
Revenue Growth TTM (YoY)19.50%
EBITD / Share (TTM)$14.29
ROE (5Y Avg)14.96%
Operating Margin (TTM)15.32%
Cash Flow / Share (Annual)$10.24
P/B Ratio3.52x
P/B Ratio (Quarterly)4.04x
Net Income / Employee (Annual)$0
EV / Revenue (TTM)2.67x
Net Interest Coverage (TTM)9.42x
ROA (TTM)10.57%
EPS Growth QoQ (YoY)7.06%
EV / EBITDA (TTM)14.43x
EPS Incl Extra (Annual)$8.75
Current Ratio (Annual)2.69x
Quick Ratio (Quarterly)1.45x
3-Month Avg Trading Volume0.18M
52-Week Price Return-5.86%
EV / Free Cash Flow (Annual)20.36x
P/E Incl Extra (TTM)21.86x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$36.69
P/S Ratio (Annual)2.48x
Asset Turnover (Annual)0.92x
52-Week High$274.93
Operating Margin (5Y Avg)14.34%
EPS Excl Extra (Annual)$8.75
CapEx CAGR (5Y)24.22%
Tangible BV CAGR (5Y)12.48%
26-Week Price Return-0.10%
Quick Ratio (Annual)1.45x
13-Week Price Return-24.21%
Total Debt / Equity (Annual)0.32x
Current Ratio (Quarterly)2.69x
Enterprise Value$1,608.252
Revenue / Share Growth (5Y)26.76%
Asset Turnover (TTM)0.93x
Book Value / Share Growth (5Y)18.43%
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)4.96x
Pretax Margin (Annual)13.69%
Cash / Share (Annual)$2.63
3-Month Return Std Dev43.79%
Gross Margin (5Y Avg)27.14%
Net Income / Employee (TTM)$0
EBITDA CAGR (5Y)35.21%
EBITDA Interim CAGR (5Y)37.07%
ROE (Last FY)16.12%
Net Interest Coverage (Annual)9.42x
EPS Basic Excl Extra (Annual)$8.75
P/FCF (TTM)18.90x
Receivables Turnover (TTM)7.19x
EV / Free Cash Flow (TTM)20.36x
Total Debt / Equity (Quarterly)0.32x
EPS Incl Extra (TTM)$8.76
Receivables Turnover (Annual)7.19x
ROI (TTM)12.41%
P/S Ratio (TTM)2.48x
Pretax Margin (5Y Avg)13.36%
Revenue / Share (Annual)$77.24
Tangible BV / Share (Annual)$36.69
Forward P/E20.43x
Free OCF CAGR (5Y)30.75%
Price vs S&P 500 (52W)-35.69%
P/E Ratio (TTM)21.86x
EPS Growth TTM (YoY)15.56%
Year-to-Date Return-11.62%
5-Day Price Return-3.62%
EPS Normalized (Annual)$8.75
ROA (5Y Avg)9.35%
Net Profit Margin (Annual)11.33%
Month-to-Date Return1.35%
Cash Flow / Share (TTM)$6.87
EBITD / Share (Annual)$14.28
EPS Growth (3Y)17.26%
Operating Margin (Annual)15.32%
LT Debt / Equity (Annual)0.29x
P/CF (TTM)16.25x
ROI (5Y Avg)11.52%
P/E Excl Extra (TTM)21.86x
LT Debt / Equity (Quarterly)0.29x
EPS Basic Excl Extra (TTM)$8.76
P/TBV (Quarterly)6.05x
P/B Ratio (Annual)4.04x
Inventory Turnover (TTM)4.96x
Pretax Margin (TTM)13.69%
Book Value / Share (Annual)$54.95
Price vs S&P 500 (13W)-24.89%
Net Margin Growth (5Y)8.69%
Beta1.16x
P/FCF (Annual)18.90x
Revenue / Share (TTM)$76.62
ROE (TTM)17.36%
52-Week Low$182.87
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
3.90
3.90
3.90
3.90
Industry Peers — Surgical & Medical Instruments(108)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
UFPTUFP Technologies Inc | 2.48x | 27.43% | 28.27% | 15.32% | $194.04 |
SYKStryker Corporation | 5.15x | 11.84% | 64.57% | 19.43% | $338.38 |
BSXBoston Scientific Corp. | 4.76x | 15.16% | 69.01% | 18.00% | $63.42 |
MMM3M Company | 3.18x | -4.97% | 39.92% | 18.55% | $150.55 |
MDLNMedline Inc. Class A common stock | 2.21x | — | 26.44% | 7.78% | $46.94 |
BDXBecton, Dickinson and Co. | 2.01x | 6.32% | 46.42% | 12.15% | $154.82 |
RMDResMed Inc. | 6.06x | 11.72% | 60.85% | 33.70% | $224.72 |
DXCMDexCom, Inc. | 5.23x | 19.33% | 62.09% | 19.56% | $61.23 |
WSTWest Pharmaceutical Services, Inc. | 6.22x | 7.44% | 35.91% | 19.03% | $269.81 |
PODDInsulet Corporation | 5.31x | 24.53% | 71.63% | 12.92% | $201.47 |
PENPenumbra, Inc. | 9.31x | 20.16% | 67.14% | 13.48% | $331.47 |
About
UFP Technologies is a contract manufacturer of single-use and single-patient medical devices for leading global medical device companies. The company employs advanced manufacturing techniques including laminating, molding, radio frequency welding, and impulse welding to produce specialized components. UFP's products serve diverse end markets including wound care, infection prevention, minimally invasive surgery, wearables, and orthopedic devices.